PFG Investments LLC Invests $94,000 in ASP Isotopes Inc. (NASDAQ:ASPI)

PFG Investments LLC bought a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 20,000 shares of the company’s stock, valued at approximately $94,000.

A number of other institutional investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets acquired a new stake in shares of ASP Isotopes during the fourth quarter worth approximately $34,000. Avantax Advisory Services Inc. acquired a new stake in ASP Isotopes in the 4th quarter valued at about $45,000. Russell Investments Group Ltd. raised its stake in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after acquiring an additional 3,682 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of ASP Isotopes during the fourth quarter worth approximately $49,000. Finally, Covestor Ltd bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $54,000. 16.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their price objective on ASP Isotopes from $8.50 to $11.00 and gave the stock a “buy” rating in a research note on Wednesday, May 21st.

ASP Isotopes Stock Performance

ASPI opened at $7.79 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.21 and a quick ratio of 7.17. The company has a market capitalization of $653.43 million, a price-to-earnings ratio of -12.77 and a beta of 3.56. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $10.08. The business’s 50-day moving average price is $7.10 and its two-hundred day moving average price is $5.71.

Insider Transactions at ASP Isotopes

In other news, COO Robert Ainscow sold 66,666 shares of the stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total transaction of $383,329.50. Following the completion of the transaction, the chief operating officer now directly owns 1,553,326 shares in the company, valued at $8,931,624.50. This represents a 4.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $1,779,662.92. Following the completion of the sale, the chief executive officer now directly owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. This represents a 4.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 766,667 shares of company stock valued at $4,358,502 over the last 90 days. 21.40% of the stock is owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.